| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
Medical Imaging Markets - Contrast Agents
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
Global |
Published |
1 November 2009 |
Number of Pages |
200 |
- |
|
Publisher |
Kalorama Information |
File Format |
- |
The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.
Since our last round-up of the contrast media market, the economic environment in the world has changed. Although the recession may have caused hospitals, physician offices and other institutions to delay or cancel the purchase of imaging equipment, it has not had a significant negative impact on the use of contrast agents with the equipment already on hand. Specifically, annual growth for medical contrast media during the next five years appears to be strong, despite the recession slowing capital equipment purchases. Imaging exams are still needed for many diagnoses, and contrast enhancement facilitates diagnosis in many cases.
Coverage includes:
- World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2012. (X-Ray, CT, Ultrasound, MRI, PET, SPECT)
- Market share of the major contrast agent supplers
- Procedure volumes by modality and region
- Estimates of the portion of procedures in each modality using contrast enhancement
- Contrast-enhancement products in development
The report also discusses technical developments and emerging application trends such as therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how contrast agents are helping to expand imaging's role in basic research and drug discovery/development. Specific advances in contrast agent-enabled diagnostics for mammography, Alzheimer's, and other indications are also reviewed.
The report concludes with profiles of top suppliers and developers including:
Acusphere Inc.
Alseres Pharmaceuticals Inc.
Amag Pharmaceuticals Inc.
Aposense Ltd.
Avid Radiopharmaceuticals Inc.
Bayer Schering Pharma
Bracco SpA
5.10 Cell Point
Covidien Ltd.
Daiichi Pharmaceutical Co. Ltd.
Dendritic NanoTechnologies Inc.
Draximage
Endocyte Inc.
Eusa Pharma
GE Healthcare
Guerbet Group
Hovione FarmaCiencia SA
Imcor Pharmaceutical Co.
Immunomedics Inc.
Insight Agents GmbH
King Pharmaceuticals Inc.
Luna nanoWorks
Macrocyclics
MDS Nordion
NanoScan Imaging
Palatin Technologies Inc.
Pharmacyclics
Point Biomedical Corp.
Starpharma Holdings Ltd.
VisEn Medical Inc.
Visitor Comments
|
All posts are pre-moderated and must obey the house rules. |
|
Last Viewed
Medical Imaging Markets - Contrast AgentsMedical Equipment Quarterly Deals Analysis Q4 2009
Medical Equipment Monthly Deals Analysis – October 2009
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - March 2010
Medical Equipment Monthly Deals Analysis - February 2010
Healthcare and Medical Company Profiles
Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.
Become an Affiliate
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).
Custom Research
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.
News
GlaxoSmithKline and AstraZeneca launch pioneering approach to antibiotic research
BD and Heart to Heart to strengthen healthcare in Haiti
Avery Dennison announces partnership with Preventice
Capita plc announces acquisition of Medicals Direct
Herbal supplements market forecast to reach $107 billion by 2017
